5-Chloro-3-(m-tolyl)-1,2,4-thiadiazole

Catalog No. :
ACZXQM987
CAS No. :
1221342-38-6
Molecular Formula :
C9H7ClN2S
Molecular Weight :
210.69

IUPAC Name:5-chloro-3-(m-tolyl)-1,2,4-thiadiazole

5-Chloro-3-(m-tolyl)-1,2,4-thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$112.00Login to see priceInquiryInquiry
100mg97%$155.00Login to see priceInquiryInquiry
250mg97%$215.00Login to see priceInquiryInquiry
1g97%$417.00Login to see priceInquiryInquiry
5g97%$868.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-3-(m-tolyl)-1,2,4-thiadiazole
IUPAC Name5-chloro-3-(m-tolyl)-1,2,4-thiadiazole
MDL No.MFCD14707352
Molecular FormulaC9H7ClN2S
Molecular Weight210.69
SMILESCC1=CC(C2=NSC(Cl)=N2)=CC=C1
InChI KeyNQMANBSOUSXOOI-UHFFFAOYSA-N
Synonym5-chloro-3-(3-methylphenyl)-1,2,4-thiadiazole;1,2,4-Thiadiazole, 5-chloro-3-(3-methylphenyl)-
CAS No.1221342-38-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZXQM987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUNQ805 route compound structure diagram
    ACEUNQ80517933-03-8 In Stock
  2. Plus
  3. ACYXMV437 route compound structure diagram
    ACYXMV43737159-60-7 In Stock
  4. Then
  5. ACZXQM987 route product structure diagram
    ACZXQM9871221342-38-6
Inquiry

2. ACZXQM987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUNQ805 route compound structure diagram
    ACEUNQ80517933-03-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZXQM987 route product structure diagram
    ACZXQM9871221342-38-6
Inquiry

Comments (0)